Natus Medical Revenue

BABY -- USA Stock  

USD 32.55  0.50  1.56%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Natus Medical 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
504.92 M

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition
Based on latest financial disclosure Natus Medical Incorporated reported 504.92 M of revenue. This is 92.23% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Revenue for all stocks is 94.87% higher than the company.

Peer Comparison

Natus Medical Revenue Comparison
  Revenue 
      Natus Medical Comparables 
Natus Medical is currently under evaluation in revenue category among related companies.

Current Natus Medical financial ratios

Return On Equity(5.68) %
Return On Asset0.55 %
Profit Margin(4.71) %
Operating Margin1.19 %
Current Valuation1.24 B
Shares Outstanding33.1 M
Shares Owned by Insiders4.29 %
Shares Owned by Institutions92.33 %
Number of Shares Shorted1.71 M
Price to Earning67.16 times
Price to Book2.85 times
Price to Sales2.38 times
Revenue504.92 M
Gross Profit287.59 M
EBITDA35.15 M
Net Income(23.79 M)
Cash and Equivalents64.47 M
Cash per Share1.97 times
Total Debt129.33 M
Debt to Equity31.00 %
Current Ratio3.06 times
Book Value Per Share12.72 times
Cash Flow from Operations24.77 M
Short Ratio7.51 times
Earnings Per Share0.73 times
Price to Earnings To Growth1.02 times
Number of Employees1.73 K
Beta0.96
Market Capitalization1.2 B
Total Asset479.5 M
Retained Earnings149.41 M
Working Capital164.25 M
Current Asset241.36 M
Current Liabilities77.11 M
Z Score6.4


 
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">